MLL
DXCM icon

Moody Lynn & Lieberson’s DexCom DXCM Stock Holding History

Moody Lynn & Lieberson’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,600
Closed -$268K – 208
2020
Q3 		$268K Sell
2,600
-92
-3% -$9.61K 0.03% 172
2020
Q2 		$273K Sell
2,692
-29,568
-92% -$2.64M 0.03% 161
2020
Q1 		$2.17K Buy
+32,260
New +$2.01M 0.3% 61

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Moody Lynn & Lieberson's DXCM Position: Q4 2020 in Review

Moody Lynn & Lieberson sold out of DexCom (DXCM) in Q4 2020, closing a stake of 2,600 shares — an estimated $268K sold.

Moody Lynn & Lieberson first reported a position in DXCM in Q1 2020 and held it in 3 quarters. The position peaked at $273K in Q2 2020. 732 funds tracked by Wall St. Rank hold DXCM as of Q4 2020.

  • Moody Lynn & Lieberson reported no remaining DexCom position as of Q4 2020 after selling out during the quarter.
  • Moody Lynn & Lieberson sold 2,600 DexCom shares in Q4 2020, an estimated $268K.
  • Moody Lynn & Lieberson first reported a position in DexCom in Q1 2020 and held it in 3 quarters.
  • Moody Lynn & Lieberson's DexCom position peaked at $273K in Q2 2020.
  • 732 funds tracked by Wall St. Rank held DexCom as of Q4 2020.

Based on Moody Lynn & Lieberson's 13F filing for Q4 2020, filed 26 Jan 2021.